Literature DB >> 13960837

Production in mice of tolerance to the toxic manifestations of Candida albicans.

H F HASENCLEVER, W O MITCHELL.   

Abstract

Hasenclever, H. F. (National Institutes of Health, Bethesda, Md.) and William O. Mitchell. Production in mice of tolerance to the toxic manifestations of Candida albicans. J. Bacteriol. 84:402-409. 1962. - Lethal toxic manifestations of Candida albicans in mice were demonstrated by the intravenous injection of 10(7) viable yeast cells. Untreated control animals had an average survival time of 4.5 to 10 hr after challenge. No multiplication of C. albicans could be demonstrated in the tissues of untreated infected controls 12 hr after challenge. Mice infected ip with C. albicans 6 days before iv challenge survived for periods three to four times longer than controls. Mice previously infected with other fungi also demonstrated tolerance to the toxicity of C. albicans. Coccidioides immitis and C. stellatoidea were especially effective. High-titer rabbit antiserum to viable C. albicans yeast cells was not protective. Studies of total and differential peripheral leukocytes indicated that mice in the tolerant state demonstrated a slight granulocytosis. Direct evidence of the protective effect of the granulocytic response was not shown

Entities:  

Keywords:  ENDOTOXINS; MONILIASIS

Mesh:

Substances:

Year:  1962        PMID: 13960837      PMCID: PMC277890          DOI: 10.1128/jb.84.3.402-409.1962

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  8 in total

1.  Active immunization of mice against Candida albicans.

Authors:  S MOURAD; L FRIEDMAN
Journal:  Proc Soc Exp Biol Med       Date:  1961-03

2.  Pathogenicity of Candida.

Authors:  S MOURAD; L FRIEDMAN
Journal:  J Bacteriol       Date:  1961-04       Impact factor: 3.490

3.  The effects of cortisone on experimental fungus infections.

Authors:  D B LOURIA; H G BROWNE
Journal:  Ann N Y Acad Sci       Date:  1960-08-27       Impact factor: 5.691

4.  Lethality of cell-free extract of Candida albicans for chlortetracycline-treated mice.

Authors:  F J ROTH; W H MURPHY
Journal:  Proc Soc Exp Biol Med       Date:  1957-03

5.  Endotoxin in pathogenic q fungi.

Authors:  S B SALVIN
Journal:  J Immunol       Date:  1952-07       Impact factor: 5.422

6.  Effect of vaccines prepared from Histoplasma capsulatum and other yeasts on experimental tuberculosis.

Authors:  L W HEDGECOCK
Journal:  J Bacteriol       Date:  1961-07       Impact factor: 3.490

7.  Specific and non-specific immunity in experimental cryptococcosis in mice.

Authors:  D B LOURIA
Journal:  J Exp Med       Date:  1960-05-01       Impact factor: 14.307

8.  The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits.

Authors:  W H SHELDON; H BAUER
Journal:  J Exp Med       Date:  1959-12-01       Impact factor: 14.307

  8 in total
  11 in total

1.  Immunity to Candida albicans.

Authors:  T J Rogers; E Balish
Journal:  Microbiol Rev       Date:  1980-12

2.  Transformation of Candida albicans with a synthetic hygromycin B resistance gene.

Authors:  Luiz R Basso; Ann Bartiss; Yuxin Mao; Charles E Gast; Paulo S R Coelho; Michael Snyder; Brian Wong
Journal:  Yeast       Date:  2010-08-24       Impact factor: 3.239

3.  Genetics of resistance to infection with Candida albicans in mice.

Authors:  G Marquis; S Montplaisir; M Pelletier; P Auger; W S Lapp
Journal:  Br J Exp Pathol       Date:  1988-10

4.  Effect in mice of injection of viable Candida albicans and a cell-free sonic extract on circulating platelets.

Authors:  I A Holder; P Nathan
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

5.  Anticandidal activity of major human salivary histatins.

Authors:  T Xu; S M Levitz; R D Diamond; F G Oppenheim
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

6.  CHARACTERIZATION OF THE PYROGENICITY OF CANDIDA ALBICANS, SACCHAROMYCES CEREVISIAE, AND CRYPTOCOCCUS NEOFORMANS.

Authors:  G S KOBAYASHI; L FRIEDMAN
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

7.  Physiological and metabolic alterations accompanying systemic candidiasis in mice.

Authors:  R D Leunk; R J Moon
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

8.  Production of tolerance to the toxicity of Candida albicans by nonfungal materials.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-12       Impact factor: 3.490

9.  ENDOTOXIN-INDUCED TOLERANCE TO TOXIC MANIFESTATIONS OF CANDIDA ALBICANS.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1963-05       Impact factor: 3.490

10.  IMMUNOLOGICAL AND TOXIC DIFFERENCES BETWEEN MOUSE-VIRULENT AND MOUSE-AVIRULENT CANDIDA ALBICANS.

Authors:  H D Isenberg; J Allerhand; J I Berkman; D Goldberg
Journal:  J Bacteriol       Date:  1963-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.